First-in-human drug trial lowers high blood triglycerides – BioNews Central An oral compound was developed to lower triglycerides by selectively inhibiting Liver X Receptor in the liver and gut, offering a potential treatment for high triglyceride-related diseases. ...

An oral #compound was developed to lower #BloodTriglycerides by selectively inhibiting #LiverXReceptor in the #liver and #gut, offering a potential treatment for high triglyceride-related diseases.
#Triglycerides #Hypertriglyceridemia #Dyslipidemia